Beijing, Beijing, China The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Wu Capital, startups are often financed by ZhenFund, Social Starts, IDG Capital. The meaningful sponsors for the fund in investment in the same round are IDG Capital, Highlight Capital, Lightspeed China Partners. In the next rounds fund is usually obtained by Shunwei Capital, SIG China (SIG Asia Investments), Morningside Venture Capital.
Besides them, we counted 1 critical employee of this fund in our database.
We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Semiconductor. Among the most popular portfolio startups of the fund, we may highlight Horizon Robotics, XiaoHongChun, Yunding Technology. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
This Wu Capital works on 22 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2018.
Related Funds
| Fund Name | Location |
| Addidi Angels | - |
| Al Mohallab Kuwait Real Estate Company | - |
| Blackrock Capital LTD | - |
| Capital Group Private Markets | Beijing, Beijing, China |
| Comfort Home | China, Shaanxi, Xian Shi |
| EarlyShares | Florida, Miami, United States |
| Endeit Capital | Amsterdam, Noord-Holland, The Netherlands |
| Founderment Ventures | Aarhus, Denmark, Midtjylland |
| HBS Angels of Boston | Boston, Massachusetts, United States |
| iBelay | - |
| Lorinet Foundation | Nassau, The Bahamas |
| Lotte Homeshopping | Seoul, Seoul-t'ukpyolsi, South Korea |
| Nanjing Securities | China, Jiangsu, Nanjing |
| Raging Bull | Texas, Tyler, United States |
| Sobrato Family Foundation | - |
| Suffolk Holdings | - |
| Tech2b Incubator | Austria, Linz, Oberosterreich |
| Vintage Fund | California, Los Angeles, United States |
| Wellington Capital Management | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ray Therapeutics | $100M | 16 May 2023 | San Diego, California, United States | ||
Korro Bio | $116M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
RiVAI | 23 Sep 2021 | Futian District, Guangdong Province, China | |||
Ranok Therapeutics | $40M | 19 Aug 2021 | Hangzhou, Zhejiang, China | ||
Feiliu | $30M | 31 May 2021 | Shanghai, China | ||
Laiye | $50M | 21 Apr 2021 | Dongcheng District, Beijing, China | ||
Inipharm | $35M | 11 Nov 2020 | Seattle, Washington, United States | ||
Korro Bio | $91M | 10 Sep 2020 | Cambridge, Massachusetts, United States | ||
Citrine Medicine | $80M | 13 Jul 2020 | Cambridge, Massachusetts, United States |
– Ranok Therapeutics (Hangzhou) Co. Ltd. secured a $40m Series B funding round denominated in both U.S. dollars and Chinese yuan.
– The financing was led by Lapam Capital and Shanghai Healthcare Capital, with additional participation from Wu Capital, Zhongguancun Kaiyuan Capital and existing investors, and representatives of the new investors will join Ranok’s expanded board of directors.
– To date, Ranok has raised the equivalent of over $50m in funding.
– Laiye Raises $50M in Series C+ Funding.
– The round was co-led by the Ping An Global Voyager Fund and Shanghai Artificial Intelligence Industry Equity Investment Fund with participation from Lightspeed China Partners, Lightspeed Venture Partners, Sequoia Capital China and Wu Capital.
– The company intends to expand globally and develop products, enhance its RPA offering with native AI capability, compatibility with more operating systems like Linux and Android, deploy on all major cloud platforms, and recruit top talent.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ray Therapeutics | $100M | 16 May 2023 | San Diego, California, United States | ||
Korro Bio | $116M | 05 Jan 2022 | Cambridge, Massachusetts, United States | ||
RiVAI | 23 Sep 2021 | Futian District, Guangdong Province, China | |||
Ranok Therapeutics | $40M | 19 Aug 2021 | Hangzhou, Zhejiang, China | ||
Feiliu | $30M | 31 May 2021 | Shanghai, China | ||
Laiye | $50M | 21 Apr 2021 | Dongcheng District, Beijing, China | ||
Inipharm | $35M | 11 Nov 2020 | Seattle, Washington, United States | ||
Korro Bio | $91M | 10 Sep 2020 | Cambridge, Massachusetts, United States | ||
Citrine Medicine | $80M | 13 Jul 2020 | Cambridge, Massachusetts, United States |
